市场调查报告书
商品编码
1441198
全球切向流过滤市场规模、份额、成长分析、按产品、按技术、按应用、按最终用途 - 行业预测,2023-2030 年Global Tangential Flow Filtration Market Size, Share, Growth Analysis, By Product, By Technology, By Application, By End-use - Industry Forecast 2023-2030 |
2022年全球切向流过滤市场规模预估为21亿美元,从2023年的23.4亿美元成长到2031年的56亿美元,预测期间(2024-2031年)复合年增长率为11.53%。以此来成长。
由于对治疗糖尿病、癌症和类风湿性关节炎等各种疾病的生物製药的需求不断增长,对切向流过滤 (TFF) 技术的需求正在迅速增加。这种不断增长的需求是推动市场成长的关键因素。 TFF 具有多种优势,包括高性能、可重复性以及公司采用新的 TFF 产品,所有这些都有助于市场扩张。此外,产业投资的增加和积极的政府倡议正在推动生物製药製造领域的设施扩建以及新工具和技术的研发。 COVID-19疫苗的大规模生产也为大公司创造了新的机会。此外,最终用户越来越多地采用一次性 TFF 设备,特别是随着一次性生物加工设备在 COVID-19 疫苗生产中越来越被接受。例如,颇尔公司投资了 1.14 亿美元,以满足疫苗生产所需的一次性技术不断增长的需求。此外,TFF 相对于传统流动过滤的付加优势,如提高流速、减少产品累积、简化清洗和简化过滤器更换,有助于其高利用率和市场成长。 TFF 的连续过滤製程与自动化相结合,可减少处理时间并提高系统弹性和生产率。这些优势使得 TFF 系统成为生物製药製造不可或缺的一部分。此外,公司正在扩大市场占有率并开发创新技术。例如,Repligen Corporation 于 2021 年获得了 TFDF(切向流深度过滤)过滤器专利,可最大程度地减少滞留量并提供高助焊剂的一次性解决方案。预计此类进步和技术创新将在预测期内推动产业扩张。
Global Tangential Flow Filtration Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.34 Billion in 2023 to USD 5.60 Billion by 2031, at a CAGR of 11.53% during the forecast period (2024-2031).
Tangential flow filtration (TFF) technology is experiencing a surge in demand due to the growing need for biopharmaceuticals to address various diseases, including diabetes, cancer, and rheumatoid arthritis. This rising demand is the primary driver of market growth. TFF offers several advantages such as high performance, reproducibility, and the introduction of new TFF products by companies, all contributing to the market's expansion. Moreover, increased industry investments and supportive government initiatives have led to facility expansions and active research and development efforts for new tools and technologies in biopharmaceutical production. The mass production of the COVID-19 vaccine has also created new opportunities for major firms. Additionally, the adoption of single-use TFF equipment by end-users has increased due to the growing acceptance of single-use biological processing equipment, especially in COVID-19 vaccine production. For example, Pall Corporation invested USD 114 million to meet the rising demand for single-use technology required in vaccine production. Furthermore, the added benefits of TFF over traditional flow filtration, such as increased flow rate, reduced product build-up, simplified cleaning, and filter replacement, contribute to its high utilization rate and market growth. The continuous filtering process of TFF, coupled with automation, reduces processing time and enhances system resilience and productivity. These advantages have made TFF systems indispensable in biopharmaceutical production. Additionally, companies are enhancing their market presence and developing innovative technologies. For instance, Repligen Corporation introduced a patent in 2021 for their Tangential Flow Depth Filtering (TFDF) filter, offering a one-use solution with minimal hold-up volume and high flux. Such advancements and innovations are expected to drive industry expansion over the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tangential Flow Filtration and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Tangential Flow Filtration Market Segmental Analysis
The global tangential flow filtration market is segmented on the basis of product, technology, application, end-use, and region. Based on product, the market is segmented into Single-use Tangential Flow Filtration Systems, Reusable Tangential Flow Filtration Systems, Membrane Filters, and Filtration Accessories. In terms of technology, the market is segmented into Ultrafiltration, Microfiltration, Nanofiltration, and Others. Based on Application the market is segmented into Protein Purification, Vaccine and Viral Vectors, Antibody Purification, Raw Material Filtration, Others. Based on End-user the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic Institutes & Research Laboratories. Based on region the global Tangential Flow Filtration Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Tangential Flow Filtration Market
The increasing need for biopharmaceuticals like monoclonal antibodies, vaccines, and recombinant proteins serves as a key catalyst for the TFF market. TFF finds extensive application in the biopharmaceutical sector for purifying and concentrating these products.
Restraints in the Global Tangential Flow Filtration Market
Introducing TFF systems can entail considerable initial expenses for equipment, consumables, and infrastructure. Moreover, ongoing operational costs related to maintenance, validation, and cleaning can be substantial. These factors might limit the uptake of TFF, especially among small and medium-sized enterprises operating within constrained budgets.
Market Trends of the Global Tangential Flow Filtration Market
The adoption of single-use TFF systems is on the rise in the market. Single-use TFF provides numerous benefits such as decreased risk of cross-contamination, streamlined cleaning and validation procedures, and enhanced operational adaptability. The convenience and cost-efficiency of single-use systems are fuelling their incorporation across diverse biopharmaceutical manufacturing operations.
The demand for TFF systems with greater capacity and throughput is escalating alongside the rising production volumes of biopharmaceuticals. Market participants are concentrating on creating high-capacity TFF systems capable of managing larger quantities of feedstock, thereby enhancing process efficiency. These systems facilitate increased productivity and scalability, meeting the industry's requirements for large-scale bioprocessing.
Rise of Comprehensive TFF Solutions: Integrated TFF platforms, which amalgamate various functions like TFF, viral clearance, and ultrafiltration, are increasingly becoming popular in the industry. These unified platforms provide streamlined operations, minimized space requirements, and enhanced process oversight. They facilitate smoother and more effective processes, lessening the reliance on separate systems and elevating manufacturing efficiency as a whole.
Embracing Enhanced TFF Membranes and Materials: Industry participants are consistently dedicating resources to research and innovation to advance TFF membrane technologies and create novel materials. The emphasis lies in refining membranes to boost selectivity, flux rates, and resistance to fouling, aiming to optimize TFF procedures. Additionally, exploration of innovative materials and coatings is underway to tackle distinct filtration hurdles and enhance overall operational efficacy.